Alphatec Holdings, Inc.

NASDAQ:ATEC

Medical - Devices

Healthcare
$7.06 +3.97%

+$0.33 today

Market cap
$1.10B
Beta
0.87
P/E (TTM)
-10.5
EPS (TTM)
-$0.81
52W Low $6.82High $23.29

Volume 2.80M

Average 3.21M

ATEC Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Alphatec Holdings, Inc.NASDAQ: ATEC

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense turns positive

Q1 FY2026 income tax expense was $50K, compared with -$64K a year earlier. Trailing-twelve-month income tax expense was $69K.

Context

  • Income tax expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly income tax expense holds near $50K or moves back toward the trailing-twelve-month quarterly average of $17.25K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$50K+377.8% QoQ
Last fiscal yearDec 2025
-$45K-190.0% YoY
LTMMar 2026
$69K+25.5% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+178.1%——
1 year-190.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
(45K) USD
Year-over-year change
-190.0%

Income Tax Expense vs competitors

How ATEC compares with its peers on the latest reported figures

  • ATEC's LTM Mar 2026 income tax expense of $69K is the 6th highest of the 7 companies compared; the peer median is $65.78M.
  • Its year-over-year change of +25.5% is the 5th highest of 7, against a peer median of +153.4%.
  • Income tax expense amounts to 0.0% of revenue for ATEC, versus a peer median of 2.5%.
ATEC Competitors Peer median
Income Tax Expense for ATEC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$1.42B +227.7%+57.4%5.5%
SNNSmith & Nephew plcFY2025$154M +79.1%+134.1%2.5%
GMEDGlobus Medical, Inc.LTM Jun 2026$129.49M +666.6%+10.9%4.1%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$2.08M +2112.8%+208.6%1.7%
OFIXOrthofix Medical Inc.LTM Mar 2026$495K -77.8%-12.2%0.1%
ATECAlphatec Holdings, Inc.LTM Mar 2026$69K +25.5%—0.0%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026-$40.08M -184.5%—2.4%
Peer median (excluding ATEC) $65.78M+153.4%+57.4%2.5%

Competitors are the stored peer set for ATEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue243.21M350.87M482.26M611.56M764.16M
Cost of Revenue85.45M117.81M172.06M187.3M232.27M
Gross Profit157.76M233.06M310.2M424.26M531.89M
Gross Margin64.9%66.4%64.3%69.4%69.6%
Research & Development32.02M44.03M70.12M80.72M76.27M
Selling, General & Admin229.27M300.01M374.08M450.2M498.53M
Operating Expenses285.82M380.03M483.6M560.43M614.02M
Depreciation & Amortization30.17M43.93M59.68M83.32M82.56M
EBITDA(106.88M)(102.58M)(110.59M)(53.87M)(39.7M)
EBITDA Margin-43.9%-29.2%-22.9%-8.8%-5.2%
Operating Income(128.06M)(146.98M)(173.4M)(136.17M)(82.13M)
Operating Margin-52.7%-41.9%-36.0%-22.3%-10.7%
Interest Income00000
Interest Expense7.11M5.51M16.64M24.88M21.14M
Other Income / Expenses(16.11M)(5.03M)(13.52M)(25.9M)(61.28M)
Income Before Tax(144.16M)(152.01M)(186.92M)(162.07M)(143.4M)
Pre-Tax Margin-59.3%-43.3%-38.8%-26.5%-18.8%
Income Tax Expense(1.13M)(716K)(277K)50K(45K)
Net Income(143.03M)(151.29M)(186.64M)(162.12M)(143.36M)
Net Margin-58.8%-43.1%-38.7%-26.5%-18.8%
EPS (Basic)(1.50)(1.47)(1.54)(1.13)(0.96)
EPS (Diluted)(1.50)(1.47)(1.54)(1.13)(0.96)
Weighted Avg Shares96.2M103.37M121.24M142.95M150.06M
Weighted Avg Shares (Diluted)96.2M103.37M121.24M142.95M150.06M

Alphatec Holdings, Inc.

NASDAQ:ATEC

Intrinsic Alpha fair value

Locked

Current Price

$7.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.